![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Intl.Brand | LSE:IBL | London | Ordinary Share | GB0031509804 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMEKF
EKF Diagnostics Holdings PLC
22 October 2020
EKF Diagnostics Holdings plc
("EKF", the "Company" or the "Group")
New supply orders for COVID-19 sample collection kits
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it has received initial orders for PrimeStore MTM COVID-19 sample collection devices from two new customers, the Health Service Executive ("HSE"), Ireland and a national health body in England. These orders will be fulfilled from EKF's production facilities in Penarth, South Wales and Barleben, Germany.
These orders will contribute to the expected strong Q4 performance and the Company intends to provide a further update on trading in early November.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com Christopher Mills, Non-executive Chairman Tel: +44 (0) 29 2071 0570 Julian Baines, CEO Richard Evans, FD & COO N+1 Singer Tel: 020 7496 3000 Aubrey Powell / George Tzimas (Corporate Finance) Tom Salvesen (Corporate Broking) Walbrook PR Limited Tel: +44 (0) 20 7933 8780 or ekf@walbrookpr.com Paul McManus / Lianne Cawthorne Mob: +44 (0) 7980 541 893 / +44 (0) 7584 391 303
About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com )
EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.
About PrimeStore MTM
The PrimeStore MTM sample collection device, deactivates viruses, bacteria, fungi and mycobacterium tuberculosis allowing safe sample handling and transport, greatly reducing risk of infection. The device was invented by Longhorn Vaccines and Diagnostics LLC ("Longhorn") in the US, in 2006 in preparation for a worldwide pandemic and is designed to de-activate pathogen rapidly and stabilise the RNA for up to four weeks with no requirement for cold storage. In the case of COVID-19, by deactivating the virus testing can now take place outside of containment facilities opening up capacity in more testing laboratories. With the flu season approaching, the PrimeStore MTM can also safely collect flu and COVID-19 samples in the same collection kit.
PrimeStore MTM was successfully evaluated for effective SARS-CoV-2 inactivation in a study published by PHE. The study showed that of the few transport reagents, from the 23 tested, where no residual virus was detectable, PrimeStore MTM is the only commercially available CE-marked and FDA cleared transport media. EKF is a contract manufacturer for the PrimeStore MTM sample collection device.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRABRBDGGXDDGGB
(END) Dow Jones Newswires
October 22, 2020 02:00 ET (06:00 GMT)
1 Year International Brand Licensing Chart |
1 Month International Brand Licensing Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions